Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INSIST-ET: Intra-arterial Neuroprotective Strategy for Ischemic STroke Patients With Endovascular Therapy
NCT04664933Recruiting
- Start
- Dec 2020
- Primary completion
- May 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of butylphthalide in ischemic stroke. Primary endpoint: Proportion of severe adverse events at 48 hours. Started Dec 2020; status: recruiting.
02
Drugs
butylphthalide
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT04664933.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04664933.